Healthcare professionals



Serum albumin at admission for prediction of functional outcome in ischaemic stroke patients.


Cho YM, Choi IS, Bian RX, Kim JH, Han JY, Lee SG.

Department of Physical & Rehabilitation Medicine, Research Institute of Medical Sciences, Chonnam National University Medical School & Hospital, # 8, Hak-Dong, Dong-Gu, Gwangju City, 501-757, Republic of Korea.

This study aimed to investigate the effect of serum albumin at admission, measured within 24 h after stroke onset, on the functional outcome in ischaemic stroke patients. The medical records of 76 first-ever hemiplegic ischaemic stroke patients were reviewed.

Read more...
 

Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials.

Crit Care. 2008;12(2):R34. Epub 2008 Mar 4.

Jacob M, Chappell D, Conzen P, Wilkes MM, Becker BF, Rehm M.

Klinik für Anästhesiologie, Ludwig-Maximilians-Universität, Klinikum Grosshadern, Nussbaumstrasse 20, D-80336 Munich, Germany. This e-mail address is being protected from spambots. You need JavaScript enabled to view it

BACKGROUND: Small-volume resuscitation can rapidly correct hypovolemia. Hyperoncotic albumin solutions, long in clinical use, are suitable for small-volume resuscitation; however, their clinical benefits remain uncertain. METHODS: Randomized clinical trials comparing hyperoncotic albumin with a control regimen for volume expansion were sought by multiple methods, including computer searches of bibliographic databases, perusal of reference lists, and manual searching. Major findings were qualitatively summarized. In addition, a quantitative meta-analysis was performed on available survival data.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 7 of 42